Missing Data Burdens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Missing Data Burdens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Missing Data Burdens Today - Breaking & Trending Today

Niraparib Maintenance Does Not Produce Long-term OS Benefit in Recurrent Ovarian Cancer

Published: March 27, 2023

Maintenance niraparib did not produce a statistically significant overall survival benefit compared with placebo in patients with recurrent ovarian cancer, according to data from an updated exploratory OS analysis of the phase 3 ENGOT-OV16/NOVA study.

Source: onclive.com

Related Topics:

United StatesDana Farber Cancer InstituteUrsula MatulonisSociety Of Gynecologic OncologyDivision Of Gynecologic OncologySociety Of Gynecological OncologyGynecologic OncologyAnnual MeetingBrock Wilson Family ChairGynecological OncologyMaintenance TherapyPatients With Recurrent Ovarian Cancer AfterPartial ResponseOvarian CancerMaintenance NiraparibOverall Survival Os BenefitPhase 3 Engot Ov16 Nova StudyMissing Data Burdens